Free Trial

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) Receives Consensus Rating of "Hold" from Brokerages

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München logo with Finance background

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report) has been given an average recommendation of "Hold" by the six research firms that are covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating and one has issued a strong buy rating on the company.

A number of analysts recently weighed in on MURGY shares. Hsbc Global Res upgraded Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to a "hold" rating in a report on Monday, April 28th. The Goldman Sachs Group downgraded Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "strong-buy" rating to a "hold" rating in a report on Monday, March 24th.

Read Our Latest Report on Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Price Performance

Shares of OTCMKTS:MURGY traded down $0.18 during trading on Friday, hitting $12.79. 199,895 shares of the company were exchanged, compared to its average volume of 291,455. The business's 50 day moving average is $13.00 and its 200-day moving average is $11.58. The company has a market capitalization of $85.54 billion, a P/E ratio of 8.32, a price-to-earnings-growth ratio of 1.72 and a beta of 0.76. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.20. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a 1-year low of $9.29 and a 1-year high of $14.10.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The financial services provider reported $0.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.71. The company had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $19.09 billion. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München had a net margin of 8.61% and a return on equity of 18.94%. Equities analysts forecast that Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München will post 0.46 earnings per share for the current year.

About Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München

(Get Free Report

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.

Featured Articles

Analyst Recommendations for Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY)

Should You Invest $1,000 in Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Right Now?

Before you consider Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München wasn't on the list.

While Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines